129 related articles for article (PubMed ID: 22348365)
1. Pharmacological management of type 2 diabetes mellitus in patients with CKD.
Hamilton CA
J Ren Care; 2012 Feb; 38 Suppl 1():59-66. PubMed ID: 22348365
[TBL] [Abstract][Full Text] [Related]
2. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease.
Snyder RW; Berns JS
Semin Dial; 2004; 17(5):365-70. PubMed ID: 15461745
[TBL] [Abstract][Full Text] [Related]
3. Review: metformin: potential benefits and use in chronic kidney disease.
Pilmore HL
Nephrology (Carlton); 2010 Jun; 15(4):412-8. PubMed ID: 20609092
[TBL] [Abstract][Full Text] [Related]
4. Novel hypoglycaemic agents: considerations in patients with chronic kidney disease.
Game F
Nephron Clin Pract; 2014; 126(1):14-8. PubMed ID: 24434725
[TBL] [Abstract][Full Text] [Related]
5. [Use of oral hypoglycemic agents in patients with chronic kidney failure].
Libardi F; Sirolli V; Cappelli P; Bonomini M
G Ital Nefrol; 2009; 26(6):679-85. PubMed ID: 19918750
[TBL] [Abstract][Full Text] [Related]
6. [Newer anti - diabetic therapies and chronic kidney disease].
Di Lullo L; Ronco C; Barbera V; Cozzolino M; Santoboni F; Villani A; De Pascalis A; Bellasi A
G Ital Nefrol; 2017; 34(1):. PubMed ID: 28177092
[TBL] [Abstract][Full Text] [Related]
7. Promising new approaches.
Reasner CA
Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
[TBL] [Abstract][Full Text] [Related]
8. Achieving glycemic control in patients with type 2 diabetes and renal impairment.
Avogaro A; Schernthaner G
Acta Diabetol; 2013 Jun; 50(3):283-91. PubMed ID: 23212669
[TBL] [Abstract][Full Text] [Related]
9. Management of diabetes in patients with chronic kidney disease.
Ahmed Z; Simon B; Choudhury D
Postgrad Med; 2009 May; 121(3):52-60. PubMed ID: 19491540
[TBL] [Abstract][Full Text] [Related]
10. [Consensus document on treatment of type 2 diabetes in patients with chronic kidney disease].
Gómez-Huelgas R; Martínez-Castelao A; Artola S; Górriz JL; Menéndez E;
Nefrologia; 2014; 34(1):34-45. PubMed ID: 24611186
[TBL] [Abstract][Full Text] [Related]
11. Glycemic control in diabetic CKD patients: where do we stand?
Kovesdy CP; Sharma K; Kalantar-Zadeh K
Am J Kidney Dis; 2008 Oct; 52(4):766-77. PubMed ID: 18572289
[TBL] [Abstract][Full Text] [Related]
12. DPP-4 inhibitors and GLP-1 analogues: for whom? Which place for incretins in the management of type 2 diabetic patients?
Halimi S
Diabetes Metab; 2008 Feb; 34 Suppl 2():S91-5. PubMed ID: 18640591
[TBL] [Abstract][Full Text] [Related]
13. Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients.
del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; Blanes-Castañer V; López-Menchero R; Gisbert-Sellés C; Sánchez-Jodar C; Alvarez-Avellán L
Nefrologia; 2012 May; 32(3):367-73. PubMed ID: 22592422
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic management of the patient with type 2 diabetes.
Quinn L
Nurs Clin North Am; 2001 Jun; 36(2):217-42, vi. PubMed ID: 11382561
[TBL] [Abstract][Full Text] [Related]
15. Incretin-based therapy in chronic kidney disease.
Pinelli NR; Moore CL; Tomasello S
Adv Chronic Kidney Dis; 2010 Sep; 17(5):439-49. PubMed ID: 20727514
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
Tandon N; Ali MK; Narayan KM
Am J Cardiovasc Drugs; 2012 Feb; 12(1):7-22. PubMed ID: 22217193
[TBL] [Abstract][Full Text] [Related]
17. Effects of oral antihyperglycemic agents in modifying macrovascular risk factors in type 2 diabetes.
Lebovitz HE
Diabetes Care; 1999 Apr; 22 Suppl 3():C41-4. PubMed ID: 10189561
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
Katavetin P; Eiam-Ong S; Suwanwalaikorn S
J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
[TBL] [Abstract][Full Text] [Related]
19. Management of drugs affecting blood glucose in diabetic patients with renal failure.
Charpentier G; Riveline JP; Varroud-Vial M
Diabetes Metab; 2000 Jul; 26 Suppl 4():73-85. PubMed ID: 10922977
[TBL] [Abstract][Full Text] [Related]
20. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
Savage S; Estacio RO; Jeffers B; Schrier RW
Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
